Date Initiated by Firm | April 30, 2012 |
Date Posted | June 02, 2012 |
Recall Status1 |
Terminated 3 on March 16, 2017 |
Recall Number | Z-1700-2012 |
Recall Event ID |
61755 |
510(K)Number | K022603 |
Product Classification |
Radioimmunoassay, immunoreactive insulin - Product Code CFP
|
Product | IMMULITE --- Insulin --- Catalog Number: LKIN1 (100 test), LKIN5 (500 tests) --- Test Code: INS, Color: Orange
Product Usage:
For in vitro diagnostic use with IMMULITE and IMMULITE 1000 Systems Analyzers --- for the quantitative measurement of insulin in serum or heparinized plasma, for the management of diabetes. |
Code Information |
kit lot 0335 |
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics 511 Benedict Ave Tarrytown NY 10591-5005
|
For Additional Information Contact | Patricia Lazarro 914-524-2955 |
Manufacturer Reason for Recall | Siemens Healthcare Diagnostics has observed a negative bias in the Immulite Insulin assay. |
FDA Determined Cause 2 | Component change control |
Action | Siemens sent an Urgent Device Recall letter dated April 2012 via fax to affected U.S. customers and an Urgent Field Safety Notice to customers outside the U.S. The letter identified the affected kit lots, reason for voluntary recall, risk to health and actions to be taken by the customer/user. Customers were instructed to discard any inventory of the affected kit lots and complete and return the attached Field Correction Effectiveness Check questionnaire within thirty (30) days to request a no-charge replacement kits. Customers were requested to post this field correction by each IMMULITE system to alert users to the situation. For questions contact your Siemens Technical Solutions Center. |
Distribution | Worldwide Distribution - US (nationwide) |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = CFP
|